Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
NCT Number: NCT04565158
The purpose of this research study is the compare objective and subjective sleep characteristics in women who have undergone removal of both ovaries (bilateral salpingo-oophorectomy) before natural menopause compared to women who did not undergo this procedure.
Looking for future studies?
Notify Me55 year and older
Female
Observational
Rochester, Minnesota, 55905, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 years
prevalence of sleep disordered breathing, insomnia, and restless legs syndrome
Time frame: 2 years
objective sleep duration from actigraphy/polysomnography and subjective sleep duration from self-report
Time frame: 2 years
objective sleep quality from actigraphy/polysomnography and subjective sleep quality from self-report
Time frame: 2 years
correlation between objective and subjective sleep measures (sleep duration, sleep quality and sleep disorders) and tests of cognitive function (attention, memory, language, and global cognitive function)
Time frame: 2 years
correlation between objective and subjective sleep measures (sleep duration, sleep quality and sleep disorders) and tests of cognitive function (attention, memory, language, and global cognitive function)
Mayo Clinic
Other
Assessment of Sleep Disruption in Women With Bilateral Salpingo-Oophorectomy - A SCORE Ancillary Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04852601
Brain Diseases, Central Nervous System Diseases
Chicago, Illinois, United States
View Trial DetailsNCT04616794
Behavior, Cognition Disorders
Montreal, Quebec, Canada
View Trial DetailsNCT06040905
Alzheimer Disease, Brain Diseases
Taichung, Taiwan
View Trial DetailsNCT07772947
Brain Diseases, Cardiovascular Diseases
Wuhan, Hubei, China
View Trial Details